Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2012
07/26/2012WO2012099630A1 Compositions and methods for treating or preventing a retrovirus infection
07/26/2012WO2012099293A1 Radiation cross-linked collagen gel, and preparation method and usage method thereof
07/26/2012WO2012099260A1 Orally dispersible tablet
07/26/2012WO2012099142A1 Bromfenac aqueous liquid composition having preservative efficiency
07/26/2012WO2012098937A1 Method for producing liposome
07/26/2012WO2012098692A1 Composition for inhibiting target gene expression
07/26/2012WO2012098562A2 Liquid oral compositions of lanthanum salts
07/26/2012WO2012098499A1 Solid molecular dispersion
07/26/2012WO2012098239A1 Microencapsulated probiotic substance and process of manufacture
07/26/2012WO2012098188A1 Glp-1 particles and compositions
07/26/2012WO2012098187A1 Glp-1 compositions
07/26/2012WO2012097978A2 Pharmaceutical compositions of immunosuppressants
07/26/2012WO2012097867A1 Cladribine particles and pharmaceutical compositions comprising them
07/26/2012WO2012097763A2 A carrier for oromucosal, especially sublingual administration of physiologically active substances
07/26/2012WO2012097429A1 Probiotic soft gel compositions
07/26/2012WO2012077968A3 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
07/26/2012WO2012075293A3 Hydrogel microcapsules
07/26/2012WO2012075174A3 Compounds and methods for skin repair
07/26/2012WO2012074830A3 Modified release tranexamic acid formulation
07/26/2012WO2012074244A3 Injectable liquid composition or injectable dried powder containing revaprazan or its salt
07/26/2012WO2012074243A3 Injectable liquid composition containing revaprazan or its salt
07/26/2012WO2012071559A3 Therapeutic methods and compositions for solid delivery
07/26/2012WO2012071280A3 Ingestible device with pharmaceutical product
07/26/2012WO2012060791A3 Production method for pharmaceutical compositions comprising cefdinir
07/26/2012WO2012060786A3 Cefpodoxime proxetil formulations comprising viscosity agent
07/26/2012WO2012059936A4 Pharmaceutical compositions for colloidal drug delivery
07/26/2012WO2012052169A3 Particulate pharmaceutical composition containing an opioid and an opioid antagonist
07/26/2012WO2012046994A9 Nitric oxide delivery system using thermosensitive synthetic polymers
07/26/2012WO2012039768A3 Itraconazole formulations
07/26/2012WO2012025730A3 Soluble film
07/26/2012WO2012024360A3 Tablet sleeve for improved performance
07/26/2012WO2012013515A3 Skin patch having optimized active substance release
07/26/2012WO2012010669A3 Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer
07/26/2012WO2011157428A3 In-situ lecithin microemulsion gel formulation
07/26/2012WO2011107921A3 Modified release composition of milnacipran
07/26/2012WO2011107283A3 Formulations of taurolidine and method for the production thereof
07/26/2012US20120190975 Nanoparticles for use in tumor diagnosis and therapy
07/26/2012US20120190722 Ketorolac tromethamine compositions for treating or preventing ocular pain
07/26/2012US20120190658 Method And Composition For The Treatment Of Adverse Skin Conditions
07/26/2012US20120189705 Pharmaceutical Compositions
07/26/2012US20120189704 Novel injectable chitosan mixtures forming hydrogels
07/26/2012US20120189703 Enzyme Delivery Systems and Methods of Preparation and Use
07/26/2012US20120189702 Cell therapy for treatment of liver failure
07/26/2012US20120189701 Combination therapy with thiocolchicine derivatives
07/26/2012US20120189700 Nanoparticle Based Immunological Stimulation
07/26/2012US20120189699 Polysaccharide gel formulation having multi-stage bioactive agent delivery
07/26/2012US20120189698 Pharmaceutical Dosage Forms for the Release of Active Compounds
07/26/2012US20120189697 Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
07/26/2012US20120189696 Coating film, and granules and tablets each utilizing same
07/26/2012US20120189695 Pharmaceutical dosage form
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189692 Pharmaceutical Compositions of Iron for Oral Administration
07/26/2012US20120189691 Drug carrier and drug carrier kit for inhibiting fibrosis
07/26/2012US20120189690 Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189687 Compositions and Methods for Topical Application of Growth Factors and Cytokines
07/26/2012US20120189686 Transdermal levonorgestrel device and delivery
07/26/2012US20120189685 Wound dressing comprising an anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group iv of the periodic system of elements
07/26/2012US20120189684 Skincare Compositions
07/26/2012US20120189683 Composite of amorphous calcium phosphate/calcium sulfate hemihydrate (csh/acp) for bone implantation and process for producing the same
07/26/2012US20120189679 Method for coating powders
07/26/2012US20120189678 Liposome and Personal Care Composition Comprising Thereof
07/26/2012US20120189677 Formulations
07/26/2012US20120189674 Compositions for topical delivery of the pharmacologically active compounds
07/26/2012US20120189673 Polypeptides and uses thereof
07/26/2012US20120189672 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
07/26/2012US20120189671 Absorbable Implants and Methods for their use in Hemostasis
07/26/2012US20120189670 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
07/26/2012US20120189669 Solid Forms for Tissue Repair
07/26/2012US20120189668 Hydrogel bioscaffold and coating for bone and tooth repair
07/26/2012US20120189667 Method for repairing or replacing damaged tissue
07/26/2012US20120189666 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
07/26/2012US20120189602 Treatment and prevention of pulmonary conditions
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012US20120189557 Topical Delivery with a Carrier Fluid
07/26/2012US20120189556 Pharmaceutical compositions based on anticholinergics and corticosteroids
07/26/2012US20120189555 Methods and compositions for prevention or treatment of rsv infection
07/26/2012US20120189553 Dental cleaning composition for evidencing dental plaque
07/26/2012US20120187591 Silk nanospheres and microspheres and methods of making same
07/26/2012CA2861357A1 Topical minocycline compositions and methods of using the same
07/26/2012CA2825014A1 Controlled release oral pharmaceutical dosage forms comprising mgbg
07/26/2012CA2825011A1 Microencapsulated probiotic substance and process of manufacture
07/26/2012CA2824933A1 Pharmaceutical compositions and methods for making and using them
07/26/2012CA2824526A1 Pegylated lipids and their use for drug delivery
07/26/2012CA2824433A1 Aqueous liquid bromfenac composition having preservative efficacy
07/26/2012CA2824430A1 Orally dispersible tablet
07/26/2012CA2824317A1 Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
07/26/2012CA2823686A1 Radiation cross-linked collagen gel, and preparation method and usage method thereof
07/26/2012CA2823622A1 Solid molecular dispersion of fesoterodine
07/26/2012CA2816538A1 Probiotic soft gel compositions
07/25/2012EP2478919A1 Osmotic pump controlled release tablet and preparation method thereof
07/25/2012EP2478914A1 Modified erythropoietin to which water-soluble long-chain molecule is added
07/25/2012EP2478909A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol
07/25/2012EP2478908A2 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/25/2012EP2478906A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/25/2012EP2478904A1 A pharmaceutical composition for peroral administration of diindolylmethane
07/25/2012EP2478902A1 Pharmaceutical composition for reducing weight and method for the production thereof
07/25/2012EP2478900A1 Monohydrate creatins intended for regulating the hormone secretions and infertility of the cycle, in vitro fertilisation and artificial insemination
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 2991